Literature DB >> 858947

Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines.

Y S Shvartsman, E N Agranovskaya, M P Zykov.   

Abstract

The formation of secretory and circulating antibodies in volunteer teenagers and adults immunized intranasally with live and inactivated influenza virus vaccines has been studied. The antibody response to the vaccine was directly dependent upon the amount of virus contained in the inoculum. The live vaccine was more effective than the inactivated vaccine in stimulating the production of secretory antibodies. Antibody levels in serum before immunization did not affect the production of secretory and circulatory antibodies. However, production of both of these antibodies was observed to be inversely correlated with the initial level of secretory antibodies. Secretory antibodies were shown to have a wider spectrum of activity against type A influenza viruses than circulating antibodies. Antibody titers in nasal secretions were correlated with the concentration of IgA in total protein but could not be correlated with concentrations of IgG.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 858947     DOI: 10.1093/infdis/135.5.697

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

Review 1.  Mucosal vaccines for the prevention of influenza.

Authors:  R L Clancy
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

2.  Selective induction of an immune response in human external secretions by ingestion of bacterial antigen.

Authors:  J Mestecky; J R McGhee; R R Arnold; S M Michalek; S J Prince; J L Babb
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

3.  Specific and nonspecific antibody responses in different segments of the respiratory tract in rats infected with Mycoplasma pulmonis.

Authors:  J W Simecka; P Patel; J K Davis; S E Ross; P Otwell; G H Cassell
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

4.  Heterogeneity of M-cell-associated B and T cells in human Peyer's patches.

Authors:  I N Farstad; T S Halstensen; O Fausa; P Brandtzaeg
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

5.  Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model.

Authors:  Gabriel Pedersen; Diane Major; Sarah Roseby; John Wood; Abdullah S Madhun; Rebecca J Cox
Journal:  Influenza Other Respir Viruses       Date:  2011-05-09       Impact factor: 4.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.